GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Market Closed 05-15 16:00:00 EDT

49.67

-0.83

-1.64%

盘后49.75

+0.08+0.16%

19:40 EDT

High50.25	Low49.39	Vol3.92M
Open50.15	D1 Closing50.50	Amplitude1.71%
Mkt Cap100.70B	Tradable Cap96.70B	Total Shares2.03B
T/O194.34M	T/O Rate0.20%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":49.67,"timestamp":1778875200000,"preClose":50.498924,"halted":0,"volume":3915138,"hourTrading":{"tag":"盘后","latestPrice":49.7481,"preClose":49.67,"latestTime":"19:40 EDT","volume":19117,"amount":949555.7112,"timestamp":1778888400369,"change":0.0781,"changeRate":0.001572,"amplitude":0.001572},"delay":0,"changeRate":-0.01641468638024843,"floatShares":1946891708,"shares":2027410400,"eps":3.736205,"marketStatus":"Market Closed","change":-0.828924,"latestTime":"05-15 16:00:00 EDT","open":50.15,"high":50.25,"low":49.385,"amount":194342055.259836,"amplitude":0.017129,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.736205,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":50.498924,"dividendRate":0.036518,"preHourTrading":{"tag":"盘前","latestPrice":50.18,"preClose":50.4989,"latestTime":"09:29 EDT","volume":7005,"amount":351296.96729999996,"timestamp":1778851799037,"change":-0.3189,"changeRate":-0.006315,"amplitude":0.016832},"postHourTrading":{"tag":"盘后","latestPrice":49.7481,"preClose":49.67,"latestTime":"19:40 EDT","volume":19117,"amount":949555.7112,"timestamp":1778888400369,"change":0.0781,"changeRate":0.001572,"amplitude":0.001572},"volumeRatio":1.0591412040391242,"impliedVol":0.1706,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2635065547","title":"Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635065547","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635065547?lang=en_us&edition=fundamental","pubTime":"2026-05-16 19:40","pubTimestamp":1778931634,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) is back in focus after securing a one year contract with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development, while its respiratory imaging technologies draw heightened investor attention.\nSee our latest analysis for 4DMedical.\nThe GSK contract has arrived at a time when momentum around the stock is shifting again, with the share price up 8.88% in the last day and 29.91% over the week, but down 34.12% over 30 days, while very large...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","GSKH","LU1829250122.USD","BK4588","BK7094","BK4007","4DX.AU","GSK.UK","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635039609","title":"GSK’s B-Well 2 Hepatitis B Trial Reaches Completion, Setting the Stage for Key Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2635039609","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635039609?lang=en_us&edition=fundamental","pubTime":"2026-05-16 00:30","pubTimestamp":1778862610,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The Phase 3 B-Well 2 trial from GlaxoSmithKline tests bepirovirsen in p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-b-well-2-hepatitis-b-trial-reaches-completion-setting-the-stage-for-key-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-b-well-2-hepatitis-b-trial-reaches-completion-setting-the-stage-for-key-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","SSI","GSKH","BK4532","GSK","BK4588","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635746355","title":"GSK executives acquire shares under company reward plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2635746355","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635746355?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:33","pubTimestamp":1778769185,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclosed a series of routine share dealings by senior executives under its ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","GSK.UK","BK4588","GSK","GSKH","LU1829250122.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635473240","title":"Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After New GSK Partnership On Hepatitis B Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635473240","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635473240?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:49","pubTimestamp":1778611767,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (SEHK:1177) has drawn fresh investor attention after subsidiary Chia Tai Tianqing agreed an exclusive partnership with GSK to commercialise bepirovirsen for chronic hepatitis B in mainland China.\nSee our latest analysis for Sino Biopharmaceutical.\nThe partnership news lands after a mixed price run, with the stock up 2.12% on a 1 day share price return and 6.25% over 7 days, yet down 15.37% over 90 days. The 1 year total shareholder return of 52.60% contrasts with weaker...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/assessing-sino-biopharmaceutical-sehk1177-valuation-after-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/assessing-sino-biopharmaceutical-sehk1177-valuation-after-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1589","BK1191","GSK","GSK.UK","BK1515","LU1829250122.USD","BK4588","BK4532","BK4585","DCF","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","GSKH","IE00BZ08YS42.EUR","HK0000165453.HKD","BK1521","BK4007","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634245198","title":"Halozyme Q1 Beat Driven by Royalty Outperformance, Strong Demand, Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245198","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245198?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:54","pubTimestamp":1778601257,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics (HALO) posted stronger-than-expected Q1 results, with revenue beating consensus on continued royalty-driven outperformance and sustained momentum across its Enhanze portfolio, Mo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362541513.USD","LU1162221912.USD","LU1988902786.USD","ORKA","LU1093756325.SGD","LU1791710582.SGD","LU2462157665.USD","BK4532","IE00B4R5TH58.HKD","LU1548497426.USD","LU0158827781.USD","GSK","BK4567","LU2271345857.HKD","LU0158827948.USD","LU2362540622.SGD","LU1720051108.HKD","LU0314104364.USD","IE00BJT1NW94.SGD","LU0106261372.USD","LU1791710400.SGD","BK4127","LU2028103732.USD","HALO","LU0289739699.SGD","LU0058720904.USD","IE0009355771.USD","LU2357305700.SGD","LU0390134368.USD","VRTX","LU0912757837.SGD","LU2089283258.USD","BK4139","SG9999001176.USD","LU1093756168.USD","BK4007","LU1244550221.USD","GSKH","LU0109394709.USD","LU2347655156.SGD","LU0823416689.USD","LU0053671581.USD","LU2456880835.USD","LU1035775433.USD","LU1989772923.USD","LU2236285917.USD","GSK.UK","LU0795875169.SGD","BK4516","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634436482","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634436482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634436482?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:14","pubTimestamp":1778598868,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.From continental Europe, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DBVT","LU2543165471.USD","BK4107","IEUR","IE00BFMHRM44.USD","MREO","GSKH","BK4139","SQNS","BK4142","BK4588","BK4505","BTI","CUK","BK4077","BK4532","AKTX","BK4207","LU0162691827.USD","BK4007","IE00BMPRXR70.SGD","SLN","IE00BMPRXN33.USD","BTI.AU","OPRA","LNOK","BK4023","GSK","BK4546","CLLS","BK4521","EPV","BK4141","GSK.UK","LU0072461881.USD","MTLS","CRTO","BK4020","LU0006061336.USD","AFG","TRVG","BK7062","BK4132","NOK","VOD","BK4075","LU1829250122.USD","LYG","BK4117","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634807292","title":"GSK Reports Executive Notional ADS Acquisition Under Savings Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2634807292","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634807292?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:33","pubTimestamp":1778510003,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Maya Martinez-Davis, its President for the US, acquired a small number of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-reports-executive-notional-ads-acquisition-under-savings-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-reports-executive-notional-ads-acquisition-under-savings-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","GSK.UK","GSK","GSKH","LU1829250122.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634435477","title":"GSK Moves to Complete £2 Billion Share Buyback Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2634435477","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634435477?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:09","pubTimestamp":1778479782,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has launched the fifth and final tranche of its previously announced £2 billion sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-moves-to-complete-2-billion-share-buyback-programme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-moves-to-complete-2-billion-share-buyback-programme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1829250122.USD","BK4588","GSKH","GSK","BK4007","BK4585","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118145858","title":"SBP GROUP (01177) Surges Over 4% in Afternoon Session Following Hepatitis B Treatment Collaboration Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1118145858","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118145858?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:42","pubTimestamp":1778478148,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) saw its shares rise more than 4% in the afternoon trading session. At the time of writing, the stock was up 4.05% to HK$5.65, with a turnover of HK$278 million. The catalyst for the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4585","VXUS","BK1515","BK1191","BK1589","GSK","HK0000165453.HKD","IE00BZ08YS42.EUR","LU1829250122.USD","BK4532","BK1521","BK4588","GSKH","IE00BZ08YR35.GBP","01177","IE00BZ08YT58.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634713684","title":"Sino Biopharmaceutical to Distribute GSK's Hepatitis B Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2634713684","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634713684?lang=en_us&edition=fundamental","pubTime":"2026-05-11 12:40","pubTimestamp":1778474442,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  secured a supply deal for GlaxoSmithKline's hepatitis B drug, bepirovirsen, for China, according to a Monday filing with the Hong Kong bourse.The firm's Chia Tai Tianqing Pharmaceutical Group entered into an exclusive strategic collaboration with GSK to cover the importation and distribution of bepirovirsen in mainland China for an initial term of 5.5 years at launch.Sino Biopharmaceutical's shares were up nearly 2% in midday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","GSK","IE00BZ08YR35.GBP","BK1191","BK1515","BK4588","BK4585","LU1829250122.USD","01177","BK1589","IE00BZ08YS42.EUR","BK1521","BK4007","BK4532","HK0000165453.HKD","GSKH","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164732726","title":"SBP GROUP (01177) Enters Exclusive Strategic Partnership with GlaxoSmithKline PLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1164732726","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164732726?lang=en_us&edition=fundamental","pubTime":"2026-05-11 12:30","pubTimestamp":1778473831,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., has entered into an exclusive strategic collaboration with GlaxoSmithKline PLC (\"GSK\") to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK1191","BK1515","BK1589","GSK","BK4588","BK4532","GSKH","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1829250122.USD","HK0000165453.HKD","GSK.UK","BK4585","IE00BZ08YT58.USD","01177","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633804176","title":"Halozyme announces global collaboration and license agreement with GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2633804176","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633804176?lang=en_us&edition=fundamental","pubTime":"2026-05-08 03:48","pubTimestamp":1778183319,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics (HALO) announced the company entered into a global collaboration and license agreement with GSK (GSK). Under the collaboratio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/halozyme-announces-global-collaboration-and-license-agreement-with-gsk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/halozyme-announces-global-collaboration-and-license-agreement-with-gsk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GSK","GSKH","HALO","BK4532","BK4588","BK4007","BK4585","LU1829250122.USD","LU0053671581.USD","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633160490","title":"GSK price target lowered to 2,100 GBp from 2,250 GBp at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2633160490","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633160490?lang=en_us&edition=fundamental","pubTime":"2026-05-07 10:29","pubTimestamp":1778120976,"startTime":"0","endTime":"0","summary":"Citi lowered the firm’s price target on GSK (GSK) to 2,100 GBp from 2,250 GBp and keeps a Neutral rating on the shares. Published first on TheFly –...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-lowered-to-2100-gbp-from-2250-gbp-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-lowered-to-2100-gbp-from-2250-gbp-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633160153","title":"GSK Wins Strong Shareholder Backing at 26th Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2633160153","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633160153?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:28","pubTimestamp":1778088510,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK reported that all 25 resolutions at its 26th Annual General Meeting, held as a hybrid...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-wins-strong-shareholder-backing-at-26th-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-wins-strong-shareholder-backing-at-26th-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1829250122.USD","GSKH","GSK.UK","BK4007","BK4532","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633584361","title":"Deutsche Bank  Sticks to Their Hold Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633584361","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633584361?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:06","pubTimestamp":1778087160,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank reiterated a Hold rating on GlaxoSmithKline, with a price target of p1,900.00. Ac...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-sticks-to-their-hold-rating-for-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-sticks-to-their-hold-rating-for-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633513933","title":"GSK Is Taking Steps in Right Direction, But Might Need More -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2633513933","media":"Dow Jones","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633513933?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:35","pubTimestamp":1778074500,"startTime":"0","endTime":"0","summary":"1335 GMT - GSK's drug pipeline is moving in the right direction, but the U.K. drugmaker might need to do more to counter the effect of looming patent expirations, Citi analysts say. The company plans to give an update on its broader pipeline when it reports second-quarter results, instead of an event focused on its HIV franchise in June as previously expected. The change makes sense in light of recent activity on the pipeline, with ten pivotal trial starts, five key study-data releases and two acquisitions, the analysts say. That said, the steps GSK has taken so far aren't enough to counter its large patent expirations, they add. Citi lowers its target price on GSK stock to 21 pounds from 22.50 pounds. Shares rise 1.3% to 18.81 pounds.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633003849","title":"GlaxoSmithKline (GSK) Receives a Hold from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2633003849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633003849?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:38","pubTimestamp":1778056690,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on GlaxoSmithKline, with a price target of £20.00. Holfo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSK.UK","LU1829250122.USD","GSK","GSKH","BK4588","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633036901","title":"Citi Sticks to Its Hold Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633036901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633036901?lang=en_us&edition=fundamental","pubTime":"2026-05-06 15:05","pubTimestamp":1778051124,"startTime":"0","endTime":"0","summary":"Citi analyst Graham Parry maintained a Hold rating on GlaxoSmithKline today and set a price target of £21.00. Parry covers the Healthcare sector, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-hold-rating-for-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-hold-rating-for-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633976177","title":"GSK Earnings Call Highlights Specialty Strength, H2 Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2633976177","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633976177?lang=en_us&edition=fundamental","pubTime":"2026-05-06 08:40","pubTimestamp":1778028040,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline (($GSK)) has held its Q1 earnings call. Read on for the main highlights of the call. GlaxoSmithKline’s latest earnings call struck ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-earnings-call-highlights-specialty-strength-h2-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-earnings-call-highlights-specialty-strength-h2-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633426739","title":"GSK Slips Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2633426739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633426739?lang=en_us&edition=fundamental","pubTime":"2026-05-06 00:08","pubTimestamp":1777997280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  shed 2.31% to GBP18.57 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index  falling 1.40% to 10,219.11.GSK PLC closed 18.62% below its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 6.1 million, compared to the 50-day average of 7.6 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0147},{"period":"1month","weight":-0.1408},{"period":"3month","weight":-0.1571},{"period":"6month","weight":0.0528},{"period":"1year","weight":0.3221},{"period":"ytd","weight":0.0128}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001243},{"month":3,"riseRate":0.608696,"avgChangeRate":0.019112},{"month":4,"riseRate":0.659574,"avgChangeRate":0.030828},{"month":5,"riseRate":0.404255,"avgChangeRate":-0.008998},{"month":6,"riseRate":0.586957,"avgChangeRate":0.009648},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}